Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2579PDF: 738HTML: 2297 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4102PDF: 1587HTML: 952 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1765PDF: 992HTML: 1781Tables: 179 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1376HTML: 394PDF: 819 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3531PDF: 1177HTML: 4998Incidence age-standardized rates for HL across the Mediterranean basin: 201 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2193PDF: 797HTML: 1627Figure 1: 182Table 1: 205 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1340PDF: 826HTML: 132 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2580PDF: 799HTML: 5214 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2126PDF: 1693HTML: 377 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2956PDF: 890HTML: 1947 -
Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma
1413PDF: 728HTML: 4550Figure 1: Chest radiograph: 212Figure 2: Flow cytometer analysis of pleural fluid: 183 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1783PDF: 966HTML: 143 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1525PDF: 387HTML: 211 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3550PDF: 2411HTML: 1463 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2452PDF: 784HTML: 1735 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3056PDF: 875HTML: 7163Kost Fig1: 182Kost Fig 2: 177Kost Fig3: 174Kost Fig 4: 190Kost Fig5: 184Kost fig 6: 173 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1525PDF: 538HTML: 272 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1721PDF: 769HTML: 508 -
-
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
722PDF: 464HTML: 6265 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1116PDF: 487HTML: 233 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1037PDF: 926Suppl. Files: 593HTML: 83 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1495PDF: 542HTML: 716 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3251PDF: 1709HTML: 1086 -
Osteolytic bone lesions – A rare presentation of AML M6.
1971PDF: 1095HTML: 7936Untitled: 203
1 - 45 of 45 items







